Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Operating activities
Net income	$ 147,220	$ 99,587
Adjustments to reconcile net income to net cash provided by operating activities:
Distributions from unconsolidated subsidiaries	10,734	14,542
Depreciation and amortization	149,022	119,644
Provision for bad debts	(373)	914
Equity in earnings of unconsolidated subsidiaries	(14,914)	(15,618)
Loss on extinguishment of debt	484	6,527
Gain on sale of assets and businesses	(9,129)	(9,499)
Stock compensation expense	17,175	14,227
Amortization of debt discount, premium and issuance costs	9,845	8,546
Deferred income taxes	(2,092)	(6,126)
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	23,495	(143,308)
Other current assets	(10,274)	(2,677)
Other assets	4,828	1,407
Accounts payable	(3,507)	3,913
Accrued expenses	49,391	18,752
Income taxes	9,072	19,141
Net cash provided by (used in) operating activities	380,977	129,972
Investing activities
Business combinations, net of cash acquired	(519,258)	(19,371)
Purchases of property and equipment	(121,039)	(173,800)
Investment in businesses	(12,936)	(11,374)
Proceeds from sale of assets and businesses	6,691	34,555
Net cash used in investing activities	(646,542)	(169,990)
Financing activities
Borrowings on revolving facilities	420,000	805,000
Payments on revolving facilities	(585,000)	(705,000)
Proceeds from term loans	779,904	1,139,487
Payments on term loans	(8,625)	(1,176,567)
Revolving facility debt issuance costs	(1,333)	(4,392)
Borrowings of other debt	30,134	27,571
Principal payments on other debt	(17,971)	(15,112)
Repurchase of common stock	(5,640)	(3,603)
Dividends paid to Holdings	0	0
Proceeds from exercise of stock options	1,633	1,634
Equity investment by Holdings	0	0
Decrease in overdrafts	(6,172)	(20,439)
Proceeds from issuance of non-controlling interests	2,926	8,986
Distributions to non-controlling interests	(306,427)	(9,276)
Net cash provided by (used in) financing activities	303,429	48,289
Net increase (decrease) in cash and cash equivalents	37,864	8,271
Cash and cash equivalents at beginning of period	122,549	99,029
Cash and cash equivalents at end of period	160,413	107,300
Supplemental Information
Cash paid for interest	134,378	101,341
Cash paid for taxes	40,460	46,553
Non-cash equity exchange for acquisition of U.S. HealthWorks	238,000	0
Select Medical Corporation
Operating activities
Net income	147,220	99,587
Adjustments to reconcile net income to net cash provided by operating activities:
Distributions from unconsolidated subsidiaries	10,734	14,542
Depreciation and amortization	149,022	119,644
Provision for bad debts	(373)	914
Equity in earnings of unconsolidated subsidiaries	(14,914)	(15,618)
Loss on extinguishment of debt	484	6,527
Gain on sale of assets and businesses	(9,129)	(9,499)
Stock compensation expense	17,175	14,227
Amortization of debt discount, premium and issuance costs	9,845	8,546
Deferred income taxes	(2,092)	(6,126)
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	23,495	(143,308)
Other current assets	(10,274)	(2,677)
Other assets	4,828	1,407
Accounts payable	(3,507)	3,913
Accrued expenses	49,391	18,752
Income taxes	9,072	19,141
Net cash provided by (used in) operating activities	380,977	129,972
Investing activities
Business combinations, net of cash acquired	(519,258)	(19,371)
Purchases of property and equipment	(121,039)	(173,800)
Investment in businesses	(12,936)	(11,374)
Proceeds from sale of assets and businesses	6,691	34,555
Net cash used in investing activities	(646,542)	(169,990)
Financing activities
Borrowings on revolving facilities	420,000	805,000
Payments on revolving facilities	(585,000)	(705,000)
Proceeds from term loans	779,904	1,139,487
Payments on term loans	(8,625)	(1,176,567)
Revolving facility debt issuance costs	(1,333)	(4,392)
Borrowings of other debt	30,134	27,571
Principal payments on other debt	(17,971)	(15,112)
Repurchase of common stock	0	0
Dividends paid to Holdings	(5,640)	(3,603)
Proceeds from exercise of stock options	0	0
Equity investment by Holdings	1,633	1,634
Decrease in overdrafts	(6,172)	(20,439)
Proceeds from issuance of non-controlling interests	2,926	8,986
Distributions to non-controlling interests	(306,427)	(9,276)
Net cash provided by (used in) financing activities	303,429	48,289
Net increase (decrease) in cash and cash equivalents	37,864	8,271
Cash and cash equivalents at beginning of period	122,549	99,029
Cash and cash equivalents at end of period	160,413	107,300
Supplemental Information
Cash paid for interest	134,378	101,341
Cash paid for taxes	40,460	46,553
Non-cash equity exchange for acquisition of U.S. HealthWorks	$ 238,000	$ 0